Khalid Ennibi

421 total citations
45 papers, 113 citations indexed

About

Khalid Ennibi is a scholar working on Infectious Diseases, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Khalid Ennibi has authored 45 papers receiving a total of 113 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Khalid Ennibi's work include SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (3 papers). Khalid Ennibi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (5 papers) and Animal Virus Infections Studies (3 papers). Khalid Ennibi collaborates with scholars based in Morocco, France and United States. Khalid Ennibi's co-authors include Abdelilah Laraqui, Tahar Bajjou, Jalal Nourlil, Mahmood Yaseen Hachim, Moulay Mustapha Ennaji, Yassir Sbitti, Abderrahmane Al Bouzidi, Elmostafa El Fahime, Idriss Lahlou Amine and Nadia Touil and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Frontiers in Physiology.

In The Last Decade

Khalid Ennibi

33 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Ennibi Morocco 6 29 25 19 16 14 45 113
María Jesús García-Villanueva Spain 6 33 1.1× 18 0.7× 12 0.6× 12 0.8× 17 1.2× 12 86
Carolina Artusi Italy 7 37 1.3× 45 1.8× 13 0.7× 12 0.8× 7 0.5× 11 161
Alice Mason United Kingdom 6 20 0.7× 32 1.3× 9 0.5× 7 0.4× 12 0.9× 14 145
Margaret Beach United States 4 10 0.3× 15 0.6× 13 0.7× 26 1.6× 13 0.9× 5 156
Jesus Loarce‐Martos Spain 4 52 1.8× 27 1.1× 50 2.6× 14 0.9× 15 1.1× 16 138
L. Fuertes Spain 7 21 0.7× 17 0.7× 32 1.7× 16 1.0× 8 0.6× 32 131
Priyanka Debta India 8 21 0.7× 37 1.5× 19 1.0× 45 2.8× 40 2.9× 48 248
Canan Albayrak Türkiye 8 21 0.7× 27 1.1× 25 1.3× 11 0.7× 13 0.9× 21 152
Samendra Karkhur India 9 21 0.7× 24 1.0× 25 1.3× 12 0.8× 29 2.1× 33 259
Αναστάσιος Καραμανάκος Greece 7 37 1.3× 14 0.6× 9 0.5× 12 0.8× 8 0.6× 13 126

Countries citing papers authored by Khalid Ennibi

Since Specialization
Citations

This map shows the geographic impact of Khalid Ennibi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Ennibi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Ennibi more than expected).

Fields of papers citing papers by Khalid Ennibi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Ennibi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Ennibi. The network helps show where Khalid Ennibi may publish in the future.

Co-authorship network of co-authors of Khalid Ennibi

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Ennibi. A scholar is included among the top collaborators of Khalid Ennibi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Ennibi. Khalid Ennibi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touil, Nadia, Omar Nyabi, Elmostafa El Fahime, et al.. (2025). The Use of CRISPR-Cas Systems for Viral Detection: A Bibliometric Analysis and Systematic Review. Biosensors. 15(6). 379–379.
2.
Laraqui, Abdelilah, et al.. (2025). Circulating Tumor DNA as a Biomarker for Precision Medicine in Prostate Cancer: A Systematic Review. International Journal of Molecular Sciences. 26(22). 11049–11049.
3.
Bourhia, Mohammed, Farid Khallouki, Khalid Ennibi, et al.. (2025). Uncovering Antiviral Potential of Cistus Ladanifer Extracts Against Herpes Simplex Virus 1 and Severe Acute Respiratory Syndrome Coronavirus 2 by In Vitro and In Silico Analysis. Chemistry & Biodiversity. 22(5). e202402661–e202402661. 1 indexed citations
4.
Melloul, Marouane, et al.. (2025). Genomic evolution of SARS-CoV-2 in Morocco: Insights from whole genome sequences collected from 2020 to 2024. Virus Research. 353. 199530–199530. 1 indexed citations
5.
Laraqui, Abdelilah, et al.. (2025). Diagnostic value of miR‑21 and miR‑221 as potential biomarkers for early diagnosis of prostate cancer. Molecular and Clinical Oncology. 22(5). 1–8. 2 indexed citations
6.
Laraqui, Abdelilah, et al.. (2025). Potency and Safety of KRAS G12C Inhibitors in Solid Tumors: A Systematic Review. Clinical Medicine Insights Oncology. 19. 1393452719–1393452719. 1 indexed citations
7.
Amine, Idriss Lahlou, Rabii Ameziane El Hassani, Rédouane Abouqal, et al.. (2024). Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants. Virus Research. 351. 199509–199509. 2 indexed citations
8.
Laraqui, Abdelilah, et al.. (2024). KRAS, NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients. Cancer Control. 31. 2925680227–2925680227. 4 indexed citations
9.
Belayachi, Jihane, Elmostafa El Fahime, Khalid Ennibi, et al.. (2024). Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection. Archives of Virology. 169(5). 109–109. 2 indexed citations
10.
Oumzil, Hicham, et al.. (2024). Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19. International Journal of Immunopathology and Pharmacology. 38. 2 indexed citations
11.
Laraqui, Abdelilah, et al.. (2024). Genetic Profiling of Non-Small Cell Lung Cancer in Moroccan Patients by Targeted Next-Generation Sequencing. Technology in Cancer Research & Treatment. 23. 2234030795–2234030795.
12.
Laraqui, Abdelilah, et al.. (2024). Germline mutations of TP53 gene can be a key factor in prostate cancer genesis. SHILAP Revista de lepidopterología. 641–655.
13.
Laraqui, Abdelilah, et al.. (2023). Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based Idylla TM System. Cancer Control. 30. 2915595586–2915595586. 2 indexed citations
14.
Bajjou, Tahar, et al.. (2020). Role of Training and Experience in Biosafety Practices Among Nurses Working in Level 2 or 3 Patient Containment. Applied Biosafety. 25(2). 96–103. 2 indexed citations
15.
Benkirane, Hasnae, Fatima Zahra Laamırı, Ayoub Al‐Jawaldeh, et al.. (2020). Study of Clinical and Biological Characteristics of Moroccan Covid-19 Patients With and Without Olfactory and/or Gustatory Dysfunction. Frontiers in Physiology. 11. 595005–595005. 4 indexed citations
16.
Ennibi, Khalid, et al.. (2018). Relapsing fever in a Moroccan man. Médecine et Santé Tropicales. 28(2). 141–143. 1 indexed citations
17.
Ennibi, Khalid, et al.. (2016). Neuropathie périphérique sous Infliximab: étude d’une observation. Pan African Medical Journal. 24. 271–271. 2 indexed citations
18.
Ennibi, Khalid, et al.. (2016). Spondylodiscite granulomateuse: surtout la tuberculose mais ne pas omettre le lymphome. Pan African Medical Journal. 25. 98–98. 1 indexed citations
19.
Ennibi, Khalid, et al.. (2013). Nocardiose pulmonaire et sarcoïdose. Revue de Pneumologie Clinique. 69(3). 139–143. 3 indexed citations
20.
Ennibi, Khalid, et al.. (2007). Épidurite révélatrice d’une maladie de Hodgkin. Revue Neurologique. 163(11). 1109–1112. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Jesús García-Villanueva Breakdown of academic impact, for papers by Carolina Artusi Breakdown of academic impact, for papers by Alice Mason Breakdown of academic impact, for papers by Margaret Beach Breakdown of academic impact, for papers by Jesus Loarce‐Martos Breakdown of academic impact, for papers by L. Fuertes Breakdown of academic impact, for papers by Priyanka Debta Breakdown of academic impact, for papers by Canan Albayrak Breakdown of academic impact, for papers by Samendra Karkhur Breakdown of academic impact, for papers by Αναστάσιος Καραμανάκος
Rankless by CCL
2026